Timothy E. Morris has served as a member of our Board since August of 2022.  Mr. Morris has served as the Chief Operating Officer of Humanetics Corporation, a privately-held advanced clinical-stage specialty pharmaceutical company, since December, 2025 and a venture partner at LongeVC, a venture capital firm dedicated to supporting exceptional early-stage founders in biotech, since June 2025.  Mr. Morris is also the founder and Managing Member of Aacolade Pharma, LLC, a boutique advisory firm assisting biotechnology and pharmaceutical companies with their fundraising, business development and governance needs since its launch in 2023.  He previously served as the Chief Financial Officer of Opthea, Limited (NASDAQ: OPT, ASX: OPT) from October, 2022 through October, 2023, and was the Chief Operating Officer and Chief Financial Officer of Humanigen, Inc. from 2020 to 2022. Mr. Morris was on the Board of Directors at Humanigen from 2016 to 2020, where he was chairman of the audit committee and a member of the compensation committee, and was also on the Board of Univercells, S.A. from 2021 to 2025 where he was chairman of the audit committee and a member of the strategic committee. Mr. Morris also served as the Chief Financial Officer of Iovance Biotherapeutics, Inc. from 2017 to 2020.  Mr. Morris has extensive Board experience, currently serving as a board member of DBV Technologies (NASDAQ: DBVT, Euronext: DBV.PA), where he serves as chairman of the audit committee and a member of the pricing committee; and Humanetics Corporation, where he serves as the chair of the audit committee and a member of the compensation committee.  Mr. Morris earned a BS in Business, with an emphasis in accounting, from California State University and is a retired Certified Public Accountant. Our Board believes that Mr. Morris’ extensive business development and company oversight experience in the pharmaceutical industry, along with his experience on the boards of public and private companies and strong finance and management background, qualifies him to serve on our Board of Directors.